Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 14/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | TACR1 | P25103 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6599095 | 0.92 | HRH1 (0.39) | TACR2ALDH1A1KDM4EMCL1L3MBTL1 | |
| SCHEMBL6598098 | 0.91 | TACR2 (0.48) | TACR2TACR1 | |
| SCHEMBL6595957 | 0.91 | TACR2 (0.46) | TACR2TACR1 | |
| SCHEMBL6595836 | 0.90 | TACR2 (0.59) | TACR2TACR1 | |
| SCHEMBL6597483 | 0.90 | TACR2 (0.47) | TACR2TACR1 | |
| SCHEMBL6596135 | 0.89 | TACR2 (0.46) | TACR2ALDH1A1KDM4EMCL1L3MBTL1 | |
| SCHEMBL6598925 | 0.89 | TACR2 (0.48) | TACR2KDM4ETACR1MAPK1 | |
| SCHEMBL6599166 | 0.89 | TACR2 (0.45) | TACR2 | |
| SCHEMBL6593512 | 0.89 | TACR2 (0.46) | TACR2TACR1 | |
| SCHEMBL6599556 | 0.89 | TACR2 (0.48) | TACR2CCR5TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2004-11-17 | — | — | EP | disclosed |